Therefore, blocking VEGF-C-VEGFR3 pathway by anti-VEGFR3 blocking antibodies in combination with paclitaxel chemotherapy significantly reduced metastasis and primary tumor growth in murine lung and breast carcinoma (Figure 2F) [58]. This evidence concerns the gene VEGFC and breast carcinoma.